You are here

Novo Nordisk

This Could Be Novo Nordisk's Next Big Weight-Loss Product

Motley Fool

Wed, 05/31/23 - 10:56 am

Pfizer's hemophilia drug hits in phase 3, giving it a chance to leapfrog Novo Nordisk

Fierce Biotech

Tue, 05/30/23 - 10:07 am

clinical trials

Noom to offer prescriptions for weight-loss drugs

Yahoo Finance

Fri, 05/26/23 - 10:05 am

Novo marks a century in business with corporate campaign launch

Medical Marketing and Media

Wed, 05/24/23 - 06:48 pm

corporate branding

Novo makes a gene editing move

EP Vantage

Wed, 05/24/23 - 10:20 am

Life Edit Therapeutics

Pfizer Stock Jumps After Diabetes Drug Tops Ozempic In Weight Loss

Investors Business Daily

Tue, 05/23/23 - 11:19 am

clinical trials

Novo Nordisk’s trial of oral semaglutide meets primary endpoint

Clinical Trials Arena

Tue, 05/23/23 - 09:56 am

oral semaglutide

clinical trials

Novo Nordisk pauses Wegovy marketing projects to dampen demand

Fierce Pharma

Mon, 05/22/23 - 11:54 am

DTC advertising

What you need to know about pharma, PBM execs testifying on insulin prices

Medical Marketing and Media

Wed, 05/10/23 - 11:15 pm

A blockbuster year could be building

EP Vantage

Wed, 05/10/23 - 09:55 am

Bristol Myers Squibb

Gilead Sciences

Horizon Therapeutics

Moderna Therapeutics

‘Robbing Peter to pay Paul’: Obesity experts debate risks of new weight loss drugs

Stat

Tue, 05/9/23 - 10:33 am

Amid high demand, Novo Nordisk temporarily throttles US supply of low-dose Wegovy

Fierce Pharma

Thu, 05/4/23 - 09:05 pm

Novo Nordisk Q1 Earnings In Line, Sales Miss, View Up

Yahoo/Zacks.com

Thu, 05/4/23 - 08:51 pm

In heavyweight obesity fight, Eli Lilly launches Mounjaro head-to-head trial against Novo Nordisk's Wegovy

Fierce Pharma

Mon, 04/24/23 - 10:20 am

clinical trials

Finding the big spenders beyond big pharma

EP Vantage

Mon, 04/24/23 - 10:15 am

Gilead Sciences

Moderna Therapeutics

Regeneron Pharmaceuticals

Vertex Pharmaceuticals

What spurred Lilly, Novo and Sanofi to slash insulin prices? Expert gives her take

Fierce Pharma

Fri, 04/21/23 - 10:22 am

Big pharma holds steady on research spending

EP Vantage

Fri, 04/21/23 - 10:03 am

With Wegovy supply unfettered, Novo Nordisk ratchets up its 2023 growth forecast

Fierce Pharma

Fri, 04/14/23 - 10:29 am

Novo’s latest deal targets cell therapy for diabetes, obesity

BioPharma Dive

Thu, 04/13/23 - 12:02 pm

Aspect Biosystems

Bernie Sanders weighs Senate hearing for largest insulin makers

Seeking Alpha

Thu, 04/13/23 - 11:53 am

Pages